IL-12-assisted immunization generates CD4+ T cell-mediated immunity to Listeria monocytogenes

Cellular Immunology

Volumn 222, Issue 1, 2003, Pages 1-14

  Miller, Mark A ^a   Skeen, Marianne J ^b   Lavine, Christy L ^a   Ziegler, H Kirk ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adjuvant; Cytokine; IL 12; Immunity; Immunization; Listeria; Vaccine

Indexed keywords

BACTERIAL VACCINE; CD4 ANTIGEN; GAMMA INTERFERON; HEAT KILLED LISTERIA MONOCYTOGENES ANTIGEN; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; IMMUNITY; IMMUNIZATION; INFECTION PREVENTION; LISTERIA MONOCYTOGENES; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STEREOCHEMISTRY; T LYMPHOCYTE; TH1 CELL; TREATMENT OUTCOME;

BACTERIA (MICROORGANISMS); LISTERIA; LISTERIA MONOCYTOGENES;

EID: 0037532323     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(03)00083-2     Document Type: Article

References (79)

1. Jones D. Foodborne listeriosis. Lancet. 336:1990;1171-1174.
2. Schuchat A., Deaver K.A., Wenger J.D., Plikaytis B.D., Mascola L., Pinner R.W., Reingold A.L., Broome C.V. Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria study group [see comments]. Jama. 267:1992;2041-2045.
3. Gellin B.G., Broome C.V. Listeriosis [see comments]. Jama. 261:1989;1313-1320.
4. Farber J.M., Peterkin P.I. Listeria monocytogenes, a food-borne pathogen [published erratum appears in Microbiol. Rev. 1991 Dec;55(4):752]. Microbiol. Rev. 55:1991;476-511.
5. Cossart P., Mengaud J. Listeria monocytogenes. A model system for the molecular study of intracellular parasitism. Mol. Biol. Med. 6:1989;463-474.
6. Wing E.J., Gregory S.H. Listeria monocytogenes: clinical and experimental update. J. Infect. Dis. 185(Suppl 1):2002;S18-S24.
7. Gedde M.M., Higgins D.E., Tilney L.G., Portnoy D.A. Role of listeriolysin O in cell-to-cell spread of Listeria monocytogenes. Infect. Immun. 68:2000;999-1003.
8. Cossart P., Bierne H. The use of host cell machinery in the pathogenesis of Listeria monocytogenes. Curr. Opin. Immunol. 13:2001;96-103.
9. Mackaness G.B. Cellular resistance to infection. J. Exp. Med. 116:1962;381-406.
10. Hahn H., Kaufmann S.H. The role of cell-mediated immunity in bacterial infections. Rev. Infect. Dis. 3:1981;1221-1250.
11. Edelson B.T., Unanue E.R. Immunity to Listeria infection. Curr. Opin. Immunol. 12:2000;425-431.
12. Conlan J.W. Early host-pathogen interactions in the liver and spleen during systemic murine listeriosis: an overview. Immunobiology. 201:1999;178-187.
13. Berche P., Gaillard J.L., Sansonetti P.J. Intracellular growth of Listeria monocytogenes as a prerequisite for in vivo induction of T cell-mediated immunity. J. Immunol. 138:1987;2266-2271.
14. von Koenig C.H., Finger H., Hof H. Failure of killed Listeria monocytogenes vaccine to produce protective immunity. Nature. 297:1982;233-234.
15. Mitsuyama M., Igarashi K., Kawamura I., Ohmori T., Nomoto K. Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes. Infect. Immun. 58:1990;1254-1260.
16. Hasenclever H.F., Karakawa W.W. Immunization of mice against Listeria monocytogenes. J. Bacteriol. 74:1957;584-586.
17. Tripp C.S., Unanue E.R. Macrophage production of IL12 is a critical link between the innate and specific immune responses to Listeria. Res. Immunol. 146:1995;515-520.
18. + T cells through IL-12 produced by Listeria-induced macrophages Science. 260:1993;547-549.
19. Liu T., Matsuguchi T., Tsuboi N., Yajima T., Yoshikai Y. Differences in expression of toll-like receptors and their reactivities in dendritic cells in BALB/c and C57BL/6 mice. Infect. Immun. 70:2002;6638-6645.
20. Liu T., Nishimura H., Matsuguchi T., Yoshikai Y. Differences in interleukin-12 and -15 production by dendritic cells at the early stage of Listeria monocytogenes infection between BALB/c and C57 BL/6 mice. Cell. Immunol. 202:2000;31-40.
21. Skeen M.J., Miller M.A., Shinnick T.M., Ziegler H.K. Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J. Immunol. 156:1996;1196-1206.
22. D'Andrea A., Rengaraju M., Valiante N.M., Chehimi J., Kubin M., Aste M., Chan S.H., Kobayashi M., Young D., Nickbarg E., Chizzonite R., Wolf S.F., Trinchieri G. Production of natural killer cell stimulatory factor (interleukin-12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1992;1387-1398.
23. Sousa C.R., Hieny S., Scharton-Kersten T., Jankovic D., Charest H., Germain R.N., Sher A. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas [see comments]. J. Exp. Med. 186:1997;1819-1829.
24. Miller M.A., Skeen M.J., Ziegler H.K. Nonviable bacterial antigens administered with IL-12 generate antigen-specific T cell responses and protective immunity against Listeria monocytogenes. J. Immunol. 155:1995;4817-4828.
25. Miller M.A., Skeen M.J., Ziegler H.K. Protective immunity to Listeria monocytogenes elicited by immunization with heat-killed Listeria and IL-12. Potential mechanism of IL-12 adjuvanticity. Ann. NY Acad. Sci. 797:1996;207-227.
26. Miller M.A., Skeen M.J., Ziegler H.K. Long-lived protective immunity to Listeria is conferred by immunization with particulate or soluble listerial antigen preparations coadministered with IL-12. Cell. Immunol. 184:1998;92-104.
27. Miller M.A., Skeen M.J., Ziegler H.K. A synthetic peptide administered with IL-12 elicits immunity to Listeria monocytogenes. J. Immunol. 159:1997;3675-3679.
28. Skeen M.J., Ziegler H.K. Activation of. γδ T cells for production of IFN-γ is mediated by bacteria via macrophage-derived cytokines IL-1 and IL-12 J. Immunol. 154:1995;5832-5841.
29. Tripp C.S., Wolf S.F., Unanue E.R. Interleukin-12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA. 90:1993;3725-3729.
30. Stoll S., Jonuleit H., Schmitt E., Muller G., Yamauchi H., Kurimoto M., Knop J., Enk A.H. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur. J. Immunol. 28:1998;3231-3239.
31. Prinz M., Hanisch U.K. Murine microglial cells produce and respond to interleukin-18. J. Neurochem. 72:1999;2215-2218.
32. Takeuchi M., Nishizaki Y., Sano O., Ohta T., Ikeda M., Kurimoto M. Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor ('interleukin-18') in mouse intestinal epithelial cells. Cell Tissue Res. 289:1997;499-503.
33. Matsui K., Yoshimoto T., Tsutsui H., Hyodo Y., Hayashi N., Hiroishi K., Kawada N., Okamura H., Nakanishi K., Higashino K. Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J. Immunol. 159:1997;97-106.
34. Udagawa N., Horwood N.J., Elliott J., Mackay A., Owens J., Okamura H., Kurimoto M., Chambers T.J., Martin T.J., Gillespie M.T. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J. Exp. Med. 185:1997;1005-1012.
35. Stoll S., Muller G., Kurimoto M., Saloga J., Tanimoto T., Yamauchi H., Okamura H., Knop J., Enk A.H. Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J. Immunol. 159:1997;298-302.
36. Nomura T., Kawamura I., Tsuchiya K., Kohda C., Baba H., Ito Y., Kimoto T., Watanabe I., Mitsuyama M. Essential role of interleukin-12 (IL-12) and IL-18 for gamma interferon production induced by listeriolysin O in mouse spleen cells. Infect. Immun. 70:2002;1049-1055.
37. Neighbors M., Xu X., Barrat F.J., Ruuls S.R., Churakova T., Debets R., Bazan J.F., Kastelein R.A., Abrams J.S., O'Garra A. A critical role for interleukin 18 in primary and memory effector responses to Listeria monocytogenes that extends beyond its effects on Interferon gamma production. J. Exp. Med. 194:2001;343-354.
38. Hunter C.A., Timans J., Pisacane P., Menon S., Cai G., Walker W., Aste-Amezaga M., Chizzonite R., Bazan J.F., Kastelein R.A. Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer. Eur. J. Immunol. 27:1997;2787-2792.
39. + T cells. Science. 248:1990;1227-1230.
40. Dalton D.K., Pitts-Meek S., Keshav S., Figari I.S., Bradley A., Stewart T.A. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes [see comments]. Science. 259:1993;1739-1742.
41. Cosgrove D., Gray D., Dierich A., Kaufman J., Lemeur M., Benoist C., Mathis D. Mice lacking MHC class II molecules. Cell. 66:1991;1051-1066.
42. Magram J., Connaughton S.E., Warrier R.R., Carvajal D.M., Wu C.Y., Ferrante J., Stewart C., Sarmiento U., Faherty D.A., Gately M.K. IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity. 4:1996;471-481.
43. Spitalny G.L., Havell E.A. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J. Exp. Med. 159:1984;1560-1565.
44. Cherwinski H.C., Schumacher J.H., Brown K.D., Mosmann T.R. Two types of mouse helper T cell clone:3. Further differences in lymphokine synthesis between TH1 and TH2 clones revealed by RNA hybridization, functionally monospecific bioassays and monoclonal antibodies. J. Exp. Med. 166:1987;1229-1244.
45. Ledbetter J.A., Herzenberg L.A. Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:1979;63-90.
46. Ledbetter J.A., Rouse R.V., Micklem H.S., Herzenberg L.A. T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J. Exp. Med. 152:1980;280-295.
47. Coligan J.E., Kruisbeek A.M., Margulies D.M., Shevach E.M., Strober W. Current Protocols in Immunology. 1991;John Wiley and Sons, New York.
48. Marshall N.E., Ziegler H.K. Lipopolysaccharide responsiveness is an important factor in the generation of optimal antigen-specific T cell responses during infection with gram-negative bacteria. J. Immunol. 147:1991;2333-2339.
49. Ziegler H.K., Orlin C.A., Cluff C.W. Differential requirements for the processing and presentation of soluble and particulate bacterial antigens by macrophages. Eur. J. Immunol. 17:1987;1287-1296.
50. Karasuyama H., Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:1988;97-104.
51. Openshaw P., Murphy E.E., Hosken N.A., Maino V., Davis K., Murphy K., O'Garra A. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1995;1357-1367.
52. Hiltbold E.M., Safley S.A., Ziegler H.K. The presentation of class I and class II epitopes of listeriolysin O is regulated by intracellular localization and by intercellular spread of Listeria monocytogenes. J. Immunol. 157:1996;1163-1175.
53. Czuprynski C.J., Canono B.P., Henson P.M., Campbell P.A. Genetically determined resistance to listeriosis is associated with increased accumulation of inflammatory neutrophils and macrophages which have enhanced listericidal activity. Immunology. 55:1985;511-518.
54. North R.J. The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J. Exp. Med. 132:1970;521-534.
55. Mackaness G.B., Hill W.C. The effect of anti-lymphocyte globulin on cell-mediated reistance to infection. J. Exp. Med. 129:1969;993-1012.
56. Kaufmann S.H., Simon M.M., Hahn H. Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens. J. Exp. Med. 150:1979;1033-1038.
57. Mittrucker H.W., Kohler A., Kaufmann S.H. Substantial in vivo proliferation of CD4(+) and CD8(+) T lymphocytes during secondary Listeria monocytogenes infection. Eur. J. Immunol. 30:2000;1053-1059.
58. Mielke M.E., Ehlers S., Hahn H. T-cell subsets in delayed-type hypersensitivity, protection, and granuloma formation in primary and secondary Listeria infection in mice: superior role of Lyt-2+ cells in acquired immunity. Infect. Immun. 56:1988;1920-1925.
59. Kaufmann S.H. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:1993;129-163.
60. Kaufmann S.H., Ladel C.H. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. Immunobiology. 191:1994;509-519.
61. Bhardwaj V., Kanagawa O., Swanson P.E., Unanue E.R. Chronic Listeria infection in SCID mice: requirements for the carrier state and the dual role of T cells in transferring protection or suppression. J. Immunol. 160:1998;376-384.
62. Mombaerts P., Arnoldi J., Russ F., Tonegawa S., Kaufmann S.H. Different roles of alpha beta and gamma delta T cells in immunity against an intracellular bacterial pathogen. Nature. 365:1993;53-56.
63. North R.J., Conlan J.W. Immunity to Listeria monocytogenes. Chem. Immunol. 70:1998;1-20.
64. + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J. Exp. Med. 175:1992;1531-1538.
65. + T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-γ but requires TNF-α J. Immunol. 160:1998;898-905.
66. White D.W., Badovinac V.P., Fan X., Harty J.T. Adaptive immunity against Listeria monocytogenes in the absence of type I tumor necrosis factor receptor p55. Infect. Immun. 68:2000;4470-4476.
67. Yeh K.Y., McAdam A.J., Pulaski B.A., Shastri N., Frelinger J.G., Lord E.M. IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes. J. Immunol. 160:1998;5773-5780.
68. Shen Z., Reznikoff G., Dranoff G., Rock K.L. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:1997;2723-2730.
69. Rock K.L., Clark K. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway. J. Immunol. 156:1996;3721-3726.
70. Chow Y.H., Chiang B.L., Lee Y.L., Chi W.K., Lin W.C., Chen Y.T., Tao M.H. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J. Immunol. 160:1998;1320-1329.
71. Wu Y.Z., Zhao J.P., Wan Y., Jia Z.C., Zhou W., Bian J., Ni B., Zou L.Y., Tang Y. Mimovirus: a novel form of vaccine that induces hepatitis B virus-specific cytotoxic T-lymphocyte responses in vivo. J. Virol. 76:2002;10264-10269.
72. Wan Y., Lu L., Bramson J.L., Baral S., Zhu Q., Pilon A., Dayball K. Dendritic cell-derived IL-12 is not required for the generation of cytotoxic, IFN-gamma-secreting, CD8(+) CTL in vivo. J. Immunol. 167:2001;5027-5033.
73. Murray H.W. Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann. Intern. Med. 108:1988;595-608.
74. Nathan C.F., Murray H.W., Wiebe M.E., Rubin B.Y. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158:1983;670-689.
75. Seder R.A., Gazzinelli R.T. Cytokines are critical in linking the innate and adaptive immune responses to bacterial, fungal, and parasitic infection. Adv. Intern. Med. 44:1999;353-388.
76. Harty J.T., Bevan M.J. Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity. 3:1995;109-117.
77. Huang S., Hendriks W., Althage A., Hemmi S., Bluethmann H., Kamijo R., Vilcek J., Zinkernagel R.M., Aguet M. Immune response in mice that lack the interferon-gamma receptor [see comments]. Science. 259:1993;1742-1745.
78. Cooper A.M., Kipnis A., Turner J., Magram J., Ferrante J., Orme I.M. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J. Immunol. 168:2002;1322-1327.
79. Oppmann B., Lesley R., Blom B., Timans J.C., Xu Y., Hunte B., Vega F., Yu N., Wang J., Singh K., Zonin F., Vaisberg E., Churakova T., Liu M., Gorman D., Wagner J., Zurawski S., Liu Y., Abrams J.S., Moore K.W., Rennick D., de Waal-Malefyt R., Hannum C., Bazan J.F., Kastelein R.A. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 13:2000;715-725.